Skip to content
Discover smart finance tips, savings strategies, and invest…

The Zimbabwean Government Declines ‘Unbalanced’ US Healthcare Assistance Agreement Over Data Apprehensions

Health funding illustration
The proposed American financial assistance would have supported programmes for treating and preventing HIV/Aids, tuberculosis, and malarial diseases.

Zimbabwe has declined a substantial US health deal valued at 367 million US dollars (£272m) spanning five years due to the United States' demand for confidential data.

This move became public after a official document from December was leaked, revealing that President Emmerson Mnangagwa felt the arrangement was "lopsided".

A government spokesperson has since clarified that the US was seeking health data for research and commercial purposes but refused to share the resulting advantages from future vaccines.

"We are forced to start the challenging and unfortunate task of scaling back our health aid in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.

The US Embassy noted the US had donated over $1.9bn for health programmes to Zimbabwe during the past twenty years.

A medical body in Zimbabwe has appealed for continued negotiations to reach a deal acceptable to all parties so the country's critical HIV programme can be sustained.

Broader Implications

Zimbabwe's decision comes after a similar situation in Kenya, where a court blocked a related deal with the US following legal challenges were filed about the security of citizens' medical information.

After returning to office last year, US President Donald Trump has drastically cut foreign aid and closed the US Agency for International Development (USAID).

The agency had administered aid for the American government, but Trump stated its spending was "inefficient" and his government was seeking direct bilateral agreements to boost transparency and accountability.

As per statements, 16 African countries have so far signed these new agreements, representing more than $18.3bn in new funding.

Details of the Declined Agreement

The money for Zimbabwe would have gone towards "combating HIV/Aids, TB, malaria, maternal and child health, and preparing for epidemics".

"We believe this collaboration might have yielded extraordinary advantages for the people of Zimbabwe, particularly the 1.2 million presently receiving HIV treatment via American-funded programmes," Tremont said.

However, official spokesman Nick Mangwana said the proposed deal was "unequal".

"Zimbabwe was being asked to share its biological resources and data indefinitely, with no equivalent guarantee of access to any medical innovations – like new medicines or tests – that might result from that shared data," his statement read.

"Put simply, our country would supply the basic resources for medical research without any certainty that the resulting innovations would be accessible to our citizens should a future pandemic arise."

Sovereignty and International Frameworks

He also pointed out that the US's withdrawal from the World Health Organization (WHO) and its push of bilateral health agreements were disrupting frameworks already established through the international organization.

The spokesperson gave as an example its Pandemic Benefit-Sharing system created to deal with future global health emergencies.

"This framework is intended to ensure that when a nation provides its samples, the benefits – such as vaccines and treatments – are shared equitably, not commercialised exclusively by those with the capability to create them."

The government's concerns over the US deal "are not meant as anti-American sentiment," he added.

"We encourage further dialogue with our American counterparts on how subsequent collaboration might be arranged in a way that respects the independence and dignity of each country."

Health Experts Response

A leading public health body said it acknowledged the government's concerns, but recommended that negotiations need to persist since much of the country's Aids initiatives depended on external financing.

"If technical issues arise, including those relating to data governance or implementation frameworks, these can frequently be addressed through detailed discussion and negotiated safeguards," it added.

The halted deal highlights the ongoing debate between accepting vital foreign assistance and safeguarding a country's data in an ever more data-driven world.

CW
The writer

Cory Ward

A seasoned financial analyst with over a decade of experience in UK personal finance and investment.

BritCashPulse

Type to search articles.